LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy
This study aimed to investigate the role of long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) in chemosensitivity of osteosarcoma (OS), and to reveal the possible underlying mechanisms. In this study, we found that the expression of lncRNA MEG3 was significantly lower in OS tissues and c...
Main Authors: | Xin Huang, Weiyue Zhang, Feifei Pu, Zhicai Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-03-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304221001288 |
Similar Items
-
Metformin displays and antitumor effect against osteosarcoma
by: Yunmi Ko, et al.
Published: (2016-09-01) -
Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
by: Binfeng Liu, et al.
Published: (2022-10-01) -
Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
by: Jun-Song Zhang, et al.
Published: (2023-03-01) -
Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
by: Yiming Zhang, et al.
Published: (2022-06-01) -
Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function
by: Zhanhu Mi, et al.
Published: (2021-07-01)